• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

FDA starts review of Padcev/Keytruda for bladder cancer

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 01, 2023 at 10:02: AM
via The FDA has kicked off a priority review of a new combination regimen for previously untreated, locally advanced or metastatic urothelial carcinoma (UC), the most common form of bladder cancer, based on MSD’s Keytruda and Astellas/Seagen’s Padcev.

article source
 




Top Bottom
Back
Quote